Deutsche Bank Aktiengesellschaft »

Bioxcel Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $52k 18k 2.95
2023-09-30 $6.2k 2.5k 2.53
2023-06-30 $90k 14k 6.66
2023-03-31 $516k 28k 18.66
2022-12-31 $519k 24k 21.48
2022-09-30 $298k 25k 11.79
2022-06-30 $355k 27k 13.19
2022-03-31 $514k 25k 20.87
2021-12-31 $581k 29k 20.31
2021-09-30 $999k 33k 30.36
2021-06-30 $704k 24k 29.05
2021-03-31 $1.0M 24k 43.14
2020-12-31 $1.1M 25k 46.19
2020-09-30 $890k 21k 43.35
2020-06-30 $1.0M 19k 52.99
2020-03-31 $349k 16k 22.34
2019-12-31 $228k 16k 14.57
2019-09-30 $0 1.7k 0.00
2019-06-30 $0 4.5k 0.00
2018-12-31 $19k 5.1k 3.69
2018-09-30 $24k 3.1k 7.74